Steris (MEX:STE N) ROCE %: 13.28% (As of Mar. 2026)


MEX:STE N Steris PLC MEX:STE N
90 GF Score
Price MXN3,824.43
GF Value MXN4,960.30
! 1 Warning Sign
View Full Analysis

What is Steris ROCE %?

Steris MEX:STE N 90 ROCE % is 13.28% as of Mar. 2026. GuruFocus rates MEX:STE N with a GF Score™ of 90/100 and a GF Value™ of MXN4,960.30. The stock has 1 warning sign investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Steris's annualized ROCE % for the quarter that ended in Mar. 2026 was 13.28%.

Steris  (MEX:STE N) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Steris ROCE % Related Terms

Steris ROCE % Historical Data

* Premium members only.

The historical data trend for Steris's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Steris ROCE % Chart

Steris Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.48 7.34 8.09 10.18 11.11

Steris Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.32 10.22 11.14 11.26 13.28
MEX:STE N
90GF Score
Steris PLC MEX:STE N
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Steris ROCE % Calculation

Steris's annualized ROCE % for the fiscal year that ended in Mar. 2026 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=19980.232/( ( (207585.264 - 20912.372) + (193620.707 - 20647.442) )/ 2 )
=19980.232/( (186672.892+172973.265)/ 2 )
=19980.232/179823.0785
=11.11 %

Steris's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=23053.004/( ( (190705.571 - 16606.657) + (193620.707 - 20647.442) )/ 2 )
=23053.004/( ( 174098.914 + 172973.265 )/ 2 )
=23053.004/173536.0895
=13.28 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 13.28% mean?
Steris (MEX:STE N) has a ROCE % of 13.28% as of Mar. 2026.
Is Steris' ROCE % too high?
Steris' current ROCE % is 13.28%. The Medical Devices & Instruments industry median ROCE % is 2.23. Steris' value of 13.28% is 495.5% above this industry median. Overall, Steris has a GF Score™ of 90/100, reflecting its overall financial health beyond just this single metric.
How does Steris' ROCE % compare to ZBH and GEHC?
Steris' ROCE % of 13.28% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.23. Steris' value of 13.28% is 495.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.23, based on 814 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Steris's current ROCE % of 13.28% is 495.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Steris's current ROCE % is 13.28%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Steris stock overvalued right now?
Steris (MEX:STE N) has a current ROCE % of 13.28%. The stock's GF Value™ is MXN4,960.30, compared to a current price of MXN3,824.43 — trading 22.9% below its estimated fair value. The current ROCE % is 13.28% and 495.5% above the Medical Devices & Instruments industry median of 2.23. Steris' overall GF Score™ is 90/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Steris (MEX:STE N), the current ROCE % is 13.28% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Steris (MEX:STE N) Overvalued in 2026?

Based on GuruFocus' analysis, Steris stock appears to be undervalued. The current stock price of MXN3,824.43 is trading 22.9% below its estimated GF Value™ of MXN4,960.30.

Key valuation signals for MEX:STE N:

  • ROCE %: 13.28%
  • GF Value™: MXN4,960.30 vs. price of MXN3,824.43 (22.9% below fair value)
  • GF Score™: 90/100 with 1 warning sign
  • Industry Position: 495.5% above the Medical Devices & Instruments median

No single metric tells the full story. See the MEX:STE N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Steris Business Description

Address 70 Sir John Rogerson\'s Quay, Dublin, IRL, D02 R296
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 20% from Applied Sterilization Technologies, or AST, and 10% from life sciences services after the divestment of its dental products business.
90GF Score

Get the complete analysis for MEX:STE N

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN3,824.43
Price
MXN4,960.30
GF Value